DalsnaFinance

FDA approves Zoryve cream for plaque psoriasis in children age 2+

Markets Investing.com By Investing.com 29 Jun 2026 23:12 1 min read
FDA approves Zoryve cream for plaque psoriasis in children age 2+

FDA approves Zoryve cream for plaque psoriasis in children age 2+

FDA approves Zoryve cream for plaque psoriasis in children age 2+

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.